Skip to main content

Table 6 HRQoL and wellbeing: Effectiveness results and statistical significance for quality of life measures

From: A randomised controlled trial and cost-consequence analysis of traditional and digital foot orthoses supply chains in a National Health Service setting: application to feet at risk of diabetic plantar ulceration

 

Traditional Supply Chaina

Digital Supply Chainb

Digital v Traditional

Point of supply (SD)

6 month (SD)

Mean change (SD)

Point of supply (SD)

6 month (SD)

Mean change (SD)

Mean effect at 6 months

Independent samples t test

EQ-5D

0.645 (0.728)

0.685 (0.261)

0.040 (0.190)

0.728 (0.239)

0.671 (0.227)

−0.057 (0.191)

−0.097

t(40) = 1.644, p = 0.108

EQ-VAS

63.91 (23.97)

62.65 (21.13)

−1.26 (19.78)

71.05 (18.83)

65.26 (19.33)

−5.79 (21.62)

−4.529

t(40) = 0.708, p = 0.483

ICECAP-A

0.730 (0.181)

0.693 (0.195)

−0.037 (0.105)

0.801 (0.173)

0.829 (0.132)

0.028 (0.107)

0.064

t(38) = −1.908, p = 0.064

  1. aN = 23 for EQ-5D and EQ-VAS, 22 for ICECAP-A, bN = 19 for EQ-5D and EQ-VAS, 18 for ICECAP-A. Due to a lack of statistical significance there is no indication that either intervention was effective at improving HRQoL, health status or capability in this study